Skip to content

ProteoFormiX: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ProteoFormiX

BE 0678.992.278
NACE 72.101, Research and development on biotechnology
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€35,284
2024 · -€7,187-€28,097
Equity
-€188,614
2024 · -€153,330-€35,284
Cash
€3,015
2024 · €11,379-€8,364
Balance sheet total
€182,817
2024 · €175,739+€7,079

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€28,590

    up €28,590 (+90.8%), from €31,474 to €60,064

    of which Trade receivables: +€31,140

  • Tangible fixed assets -€13,331

    down €13,331 (-12.4%), from €107,293 to €93,962

    of which Plant, machinery and equipment: -€24,681

  • Cash -€8,364

    down €8,364 (-73.5%), from €11,379 to €3,015

    mainly Debts after one year (-€149,000) and Net result for the year (-€35,284)

Equity and liabilities
  • Other debts +€195,456

    up €195,456 (+141%), from €139,112 to €334,568

  • Debts after one year -€149,000

    down €149,000 (-100%), from €149,000 to €0

  • Profit (loss) carried forward -€35,284

    down €35,284 (-13.0%), from -€271,879 to -€307,163

  • Accrued charges and deferred income -€18,377

    down €18,377 (-100%), from €18,377 to €0

  • Trade debts +€8,509

    up €8,509 (+37.7%), from €22,580 to €31,089

Income statement
  • Gross operating margin -€27,724

    down €27,724, from €23,082 to -€4,642

  • Financial income -€11,645

    down €11,645 (-99.2%), from €11,737 to €92

  • Financial charges -€11,197

    down €11,197 (-87.9%), from €12,734 to €1,537

  • Depreciation -€257

    down €257 (-0.9%), from €28,595 to €28,338

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€7,187
Gross operating margin -€27,724
Staff costs -€129
Depreciation +€257
Other operating charges -€68
Financial income -€11,645
Financial charges +€11,197
Taxes +€16
Result 2025 -€35,284
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€154,640
Investment -€14,004
Financing -€149,000
Cash 2024 €11,379
Net result for the year -€35,284
Depreciation +€28,338
Receivables within one year -€28,590
Deferred charges and accrued income -€1,187
Trade debts +€8,509
Tax, wage and social debts +€5,774
Other debts +€195,456
Accrued charges and deferred income -€18,377
Investment in fixed assets (net) -€14,004
Debts after one year -€149,000
Cash 2025 €3,015
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €175,739 €182,817 +€7,079 +4.0%
Fixed assets 21/28 €114,261 €99,927 -€14,334 -12.5%
Intangible fixed assets 21 €6,968 €5,965 -€1,004 -14.4%
Tangible fixed assets 22/27 €107,293 €93,962 -€13,331 -12.4%
Plant, machinery and equipment 23 €104,779 €80,098 -€24,681 -23.6%
Furniture and vehicles 24 €2,514 €8,448 +€5,934 +236%
Assets under construction and advance payments 27 - €5,416 +€5,416
Current assets 29/58 €61,477 €82,890 +€21,413 +34.8%
Amounts receivable within one year 40/41 €31,474 €60,064 +€28,590 +90.8%
Trade receivables 40 €28,923 €60,064 +€31,140 +108%
Other amounts receivable 41 €2,551 €0 -€2,551 -100%
Current investments 50/53 €18,624 €18,624 = 0.0%
Cash at bank and in hand 54/58 €11,379 €3,015 -€8,364 -73.5%
Deferred charges and accrued income 490/1 - €1,187 +€1,187
Total equity and liabilities 10/49 €175,739 €182,817 +€7,079 +4.0%
Equity 10/15 -€153,330 -€188,614 -€35,284 -23.0%
Contributions 10/11 €118,549 €118,549 = 0.0%
Profit (loss) carried forward 14 -€271,879 -€307,163 -€35,284 -13.0%
Amounts payable 17/49 €329,069 €371,431 +€42,363 +12.9%
Amounts payable after more than one year 17 €149,000 €0 -€149,000 -100%
Financial debts 170/4 €149,000 €0 -€149,000 -100%
Amounts payable within one year 42/48 €161,692 €371,431 +€209,739 +130%
Trade debts 44 €22,580 €31,089 +€8,509 +37.7%
Suppliers 440/4 €22,580 €31,089 +€8,509 +37.7%
Taxes, remuneration and social security 45 - €5,774 +€5,774
Taxes 450/3 - €5,774 +€5,774
Other amounts payable 47/48 €139,112 €334,568 +€195,456 +141%
Accrued charges and deferred income 492/3 €18,377 €0 -€18,377 -100%
Remuneration, social security and pensions 62 €56 €185 +€129 +233%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €28,595 €28,338 -€257 -0.9%
Other operating charges 640/8 €605 €673 +€68 +11.2%
Gross operating margin 9900 €23,082 -€4,642 -€27,724
Operating profit (loss) 9901 -€6,174 -€33,838 -€27,664 -448%
Financial income 75/76B €11,737 €92 -€11,645 -99.2%
Recurring financial income 75 €11,737 €92 -€11,645 -99.2%
Financial charges 65/66B €12,734 €1,537 -€11,197 -87.9%
Recurring financial charges 65 €12,734 €1,537 -€11,197 -87.9%
Profit (loss) for the period before taxes 9903 -€7,171 -€35,284 -€28,113 -392%
Income taxes 67/77 €16 €0 -€16 -99.0%
Profit (loss) for the period 9904 -€7,187 -€35,284 -€28,097 -391%
Profit (loss) for the period to be appropriated 9905 -€7,187 -€35,284 -€28,097 -391%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.